Advanced Methodologies and Techniques for Assessing Nanomaterial Toxicity: From Manufacturing to Nanomedicine Screening

Adriele Prina-Mello; Bashir M. Mohamed; Navin K. Verma; Namrata Jain; Yuri Volkov

doi:10.1201/b16562-16

Advanced Methodologies and Techniques for Assessing Nanomaterial Toxicity: From Manufacturing to Nanomedicine Screening

Adriele Prina-Mello, Bashir M. Mohamed, Navin K. Verma, Namrata Jain, Yuri Volkov

Research output: Chapter in Book/Report/Conference proceeding › Chapter

5 Citations (Scopus)

Abstract

Future innovation in nanomedicine is expected, in the next 10 years, to deliver solutions to many challenging problems faced by modern medicine in diagnostics and medical imaging of cancer, 1 theranostics, 2, 3 pharmaceuticals, 4 and regenerative medicine.5, 6 To accelerate such process, there is the need to overcome some bottlenecks such as toxicity, 7 biocompatibility, 8 pharmacoefcacy, 4, 9 and life-cycle assessment10, 11 of the engineered nanomaterials (ENMs) or engineered nanoparticles (ENPs) used as nanocarriers, nanovectors, or probes. Therefore, effective translation from research into industrial, clinical, marketable products is not going to happen until essential effort is invested into the comprehensive environmental, health, and safety characterization and assessment of the ENMs/ENPs to be used.10.

Original language	English
Title of host publication	Nanotoxicology
Subtitle of host publication	Progress toward Nanomedicine
Publisher	CRC Press
Pages	155-176
Number of pages	22
ISBN (Electronic)	9781482203929
ISBN (Print)	9781482203875
DOIs	https://doi.org/10.1201/b16562-16
Publication status	Published - Jan 1 2014
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2014 by Taylor and Francis Group, LLC.

ASJC Scopus Subject Areas

General Medicine
General Engineering
General Materials Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1201/b16562-16

Cite this

@inbook{2fd480a83c6d4f3d91fa70658dba7574,

title = "Advanced Methodologies and Techniques for Assessing Nanomaterial Toxicity: From Manufacturing to Nanomedicine Screening",

abstract = "Future innovation in nanomedicine is expected, in the next 10 years, to deliver solutions to many challenging problems faced by modern medicine in diagnostics and medical imaging of cancer, 1 theranostics, 2, 3 pharmaceuticals, 4 and regenerative medicine.5, 6 To accelerate such process, there is the need to overcome some bottlenecks such as toxicity, 7 biocompatibility, 8 pharmacoefcacy, 4, 9 and life-cycle assessment10, 11 of the engineered nanomaterials (ENMs) or engineered nanoparticles (ENPs) used as nanocarriers, nanovectors, or probes. Therefore, effective translation from research into industrial, clinical, marketable products is not going to happen until essential effort is invested into the comprehensive environmental, health, and safety characterization and assessment of the ENMs/ENPs to be used.10.",

author = "Adriele Prina-Mello and Mohamed, {Bashir M.} and Verma, {Navin K.} and Namrata Jain and Yuri Volkov",

note = "Publisher Copyright: {\textcopyright} 2014 by Taylor and Francis Group, LLC.",

year = "2014",

month = jan,

day = "1",

doi = "10.1201/b16562-16",

language = "English",

isbn = "9781482203875",

pages = "155--176",

booktitle = "Nanotoxicology",

publisher = "CRC Press",

}

TY - CHAP

T1 - Advanced Methodologies and Techniques for Assessing Nanomaterial Toxicity

T2 - From Manufacturing to Nanomedicine Screening

AU - Prina-Mello, Adriele

AU - Mohamed, Bashir M.

AU - Verma, Navin K.

AU - Jain, Namrata

AU - Volkov, Yuri

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Future innovation in nanomedicine is expected, in the next 10 years, to deliver solutions to many challenging problems faced by modern medicine in diagnostics and medical imaging of cancer, 1 theranostics, 2, 3 pharmaceuticals, 4 and regenerative medicine.5, 6 To accelerate such process, there is the need to overcome some bottlenecks such as toxicity, 7 biocompatibility, 8 pharmacoefcacy, 4, 9 and life-cycle assessment10, 11 of the engineered nanomaterials (ENMs) or engineered nanoparticles (ENPs) used as nanocarriers, nanovectors, or probes. Therefore, effective translation from research into industrial, clinical, marketable products is not going to happen until essential effort is invested into the comprehensive environmental, health, and safety characterization and assessment of the ENMs/ENPs to be used.10.

AB - Future innovation in nanomedicine is expected, in the next 10 years, to deliver solutions to many challenging problems faced by modern medicine in diagnostics and medical imaging of cancer, 1 theranostics, 2, 3 pharmaceuticals, 4 and regenerative medicine.5, 6 To accelerate such process, there is the need to overcome some bottlenecks such as toxicity, 7 biocompatibility, 8 pharmacoefcacy, 4, 9 and life-cycle assessment10, 11 of the engineered nanomaterials (ENMs) or engineered nanoparticles (ENPs) used as nanocarriers, nanovectors, or probes. Therefore, effective translation from research into industrial, clinical, marketable products is not going to happen until essential effort is invested into the comprehensive environmental, health, and safety characterization and assessment of the ENMs/ENPs to be used.10.

UR - http://www.scopus.com/inward/record.url?scp=84963803427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963803427&partnerID=8YFLogxK

U2 - 10.1201/b16562-16

DO - 10.1201/b16562-16

M3 - Chapter

AN - SCOPUS:84963803427

SN - 9781482203875

SP - 155

EP - 176

BT - Nanotoxicology

PB - CRC Press

ER -

Advanced Methodologies and Techniques for Assessing Nanomaterial Toxicity: From Manufacturing to Nanomedicine Screening

Abstract

Bibliographical note

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this